- Reported transaction lines
- 3
- Buy lines
- 0
- Sell lines
- 1
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-113
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| De Witte Jan Director · RESMED INC | RMD RESMED INC | Equity grant or awardFiling detailsSEC transaction code A ResMed Common Stock · Direct ownership · Reported balance after transaction: 4881 · Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2027, or the annual meeting of stockholders in the year following the grant date. | 2026-11-19 | 2026-11-20 | 1,109 shares/units | SEC 4 |
| De Witte Jan Director · RESMED INC | RMD RESMED INC | SellFiling detailsSEC transaction code S ResMed Common Stock · Direct ownership · Reported balance after transaction: 3772 · SEC code covers open-market or private transactions · The transaction was conducted under a Rule 10b5-1 plan adopted August 19, 2026. | 2026-11-17 | 2026-11-18 | ≈ $101,673.00 429 shares/units | SEC 4 |
| De Witte Jan Director · RESMED INC | RMD RESMED INC | Other transactionFiling detailsSEC transaction code F ResMed Common Stock · Direct ownership · Reported balance after transaction: 4201 · Securities delivered or withheld for tax or exercise payment · Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2025. | 2026-11-11 | 2026-11-13 | 59.981 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.